Noble Wealth Management PBC’s Amgen AMGN Stock Holding History

Noble Wealth Management PBC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09K	Buy	+3	New	+$1.03K	﹤0.01%	688

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Noble Wealth Management PBC's AMGN Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in Amgen (AMGN) in Q2 2026: 3 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #688 among its holdings.

1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Noble Wealth Management PBC held 3 shares of Amgen worth $1.09K as of Q2 2026.
Amgen was a new Noble Wealth Management PBC position in Q2 2026.
Amgen made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #688 holding.
1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.